» Articles » PMID: 29358413

The Hypoxia-Adenosine Link During Intestinal Inflammation

Overview
Journal J Immunol
Date 2018 Jan 24
PMID 29358413
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal inflammation is a key element in inflammatory bowel disease and is related to a combination of factors, including genetics, mucosal barrier dysfunction, bacteria translocation, deleterious host-microbe interactions, and dysregulated immune responses. Over the past decade, it has been appreciated that these inflammatory lesions are associated with profound tissue hypoxia. Interestingly, an endogenous adaptive response under the control of hypoxia signaling is enhancement in adenosine signaling, which impacts these different endpoints, including promoting barrier function and encouraging anti-inflammatory activity. In this review, we discuss the hypoxia-adenosine link in inflammatory bowel disease, intestinal ischemia/reperfusion injury, and colon cancer. In addition, we provide a summary of clinical implications of hypoxia and adenosine signaling in intestinal inflammation and disease.

Citing Articles

HIF-2α-dependent induction of miR-29a restrains T1 activity during T cell dependent colitis.

Czopik A, McNamee E, Vaughn V, Huang X, Bang I, Clark T Nat Commun. 2024; 15(1):8042.

PMID: 39271652 PMC: 11399416. DOI: 10.1038/s41467-024-52113-y.


Purinergic regulation of pulmonary vascular tone.

Alveal M, Mendez A, Garcia A, Henriquez M Purinergic Signal. 2024; 20(6):595-606.

PMID: 38713328 PMC: 11554604. DOI: 10.1007/s11302-024-10010-5.


Adenosine in Intestinal Epithelial Barrier Function.

Stepanova M, Aherne C Cells. 2024; 13(5.

PMID: 38474346 PMC: 10930693. DOI: 10.3390/cells13050381.


Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome.

Figarella K, Kim J, Ruan W, Mills T, Eltzschig H, Yuan X Front Immunol. 2024; 15:1328565.

PMID: 38312838 PMC: 10835146. DOI: 10.3389/fimmu.2024.1328565.


Interrelation of Hypoxia-Inducible Factor-1 Alpha (HIF-1 α) and the Ratio between the Mean Corpuscular Volume/Lymphocytes (MCVL) and the Cumulative Inflammatory Index (IIC) in Ulcerative Colitis.

Poenariu I, Boldeanu L, Ungureanu B, Caragea D, Cristea O, Padureanu V Biomedicines. 2023; 11(12).

PMID: 38137357 PMC: 10741094. DOI: 10.3390/biomedicines11123137.


References
1.
Allard D, Allard B, Gaudreau P, Chrobak P, Stagg J . CD73-adenosine: a next-generation target in immuno-oncology. Immunotherapy. 2016; 8(2):145-63. DOI: 10.2217/imt.15.106. View

2.
Naganuma M, Wiznerowicz E, Lappas C, Linden J, Worthington M, Ernst P . Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol. 2006; 177(5):2765-9. DOI: 10.4049/jimmunol.177.5.2765. View

3.
McColl S, St-Onge M, Dussault A, Laflamme C, Bouchard L, Boulanger J . Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 2005; 20(1):187-9. PMC: 2881301. DOI: 10.1096/fj.05-4804fje. View

4.
Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

5.
Eckle T, Koeppen M, Eltzschig H . Role of extracellular adenosine in acute lung injury. Physiology (Bethesda). 2009; 24:298-306. DOI: 10.1152/physiol.00022.2009. View